Download PDF

Register to download the report. Already a member?

Sign Up


67053 1513184208HCLSReviewBulgariaDecember2017.pdf
Energy Boardroom

Serbia Pharma Report

August 2011


  • No News

Top Story


Serbia : Serbia: Ready to Flourish

Serbia has had an undoubtedly troubled history since the breakup of Yugoslavia in the early 1990s. A costly war and ensuing UN sanctions have left the country’s economy a few years behind those of its regional counterparts. The subsequent global financial crisis in the late 2000s resulted in another hit to many of the country’s key industries, including Serbia’s pharmaceutical and healthcare sectors. These historical events explain some of the key issues that underlie the sectors’ current challenges, such as non-liquidity and inadequate funding. And while Serbia’s population currently amounts to roughly 7.3 million inhabitants, ‘it is a little-known fact that 1.2 million people have no income, and that the state provides 520 dinars (roughly $7.30) per year for them,’ asserts Serbia’s Ministry of Health.

view more

snapshot in figures

Clinical trials in Serbia

  • Associations view more
  • Interviews


    Interview: Ronald Seeliger – Vice-President, Stada South-East Europe; CEO, Hemofarm Group, Serbia

    Ronald Seeliger, CEO of Hemofarm group, arrived in Serbia during turbulent times in CEE. Following a strict program of reinvestment, local expertise, and innovative strategies, Hemofarm surged forwards, developing into the pharmaceutical powerhouse that we see today. In this interview …

    view more

    Most Read

    Download PDF

    First Name:

    Last Name: